These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

889 related items for PubMed ID: 29807226

  • 1. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C, Xie Y, Zhuang X, Yuan Z.
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [Abstract] [Full Text] [Related]

  • 2. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J, Lv J, Chen J, Zhang X, Ji Y.
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [Abstract] [Full Text] [Related]

  • 3. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
    Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z.
    Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391
    [Abstract] [Full Text] [Related]

  • 4. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L, Liu XL, Yuan Z, Cui J, Zhang H.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun 26; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF, Jamal R, Syafruddin SE, Ab Mutalib NS, Saidin S, MdZin RR, Hossain Mollah MM, Mokhtar NM.
    J Ovarian Res; 2015 Aug 12; 8():56. PubMed ID: 26260454
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.
    Qu W, Chen X, Wang J, Lv J, Yan D.
    Clin Chim Acta; 2017 Oct 12; 473():237-244. PubMed ID: 28698064
    [Abstract] [Full Text] [Related]

  • 9. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B, Yang S, Liu T, Lou G.
    Mol Cancer; 2015 Mar 11; 14():57. PubMed ID: 25889927
    [Abstract] [Full Text] [Related]

  • 10. MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.
    Liao Y, Yin X, Deng Y, Peng X.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30291212
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT, Gao JY, Wang HL, Wang Y, Wang H, Li PL.
    Genet Mol Res; 2015 Jul 31; 14(3):8766-77. PubMed ID: 26345808
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X, Dong C, Law PT, Chan MT, Su Z, Wang S, Wu WK, Xu H.
    Gynecol Oncol; 2015 Dec 31; 139(3):513-9. PubMed ID: 26472353
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
    Wei C, Zhang X, He S, Liu B, Han H, Sun X.
    Gene; 2017 Dec 30; 637():25-32. PubMed ID: 28890378
    [Abstract] [Full Text] [Related]

  • 14. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1.
    Dai T, Liang J, Liu W, Zou Y, Niu F, Li M, Zhang H, Li C, Fan M, Cui G.
    Bioengineered; 2021 Dec 30; 12(2):10771-10781. PubMed ID: 34793263
    [Abstract] [Full Text] [Related]

  • 15. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y, Sawada K, Nakamura K, Sawada I, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Takahashi K, Kurachi H, Lengyel E, Kimura T.
    Oncotarget; 2015 May 10; 6(13):11342-56. PubMed ID: 25839163
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L, Yang Q, Yuan J, Miao Q, Duan L, Li F, Wang S.
    Oncol Rep; 2016 Nov 10; 36(5):2563-2570. PubMed ID: 27571744
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L.
    PLoS One; 2014 Nov 10; 9(5):e96718. PubMed ID: 24816687
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q, Peng Y, Hu Y, Li X, Yan W, Guo K, Zhou W, Wang Y, Liu J, Zhang Y, Mor G, Wen J, Yin G.
    Oncotarget; 2016 Dec 06; 7(49):80633-80654. PubMed ID: 27811362
    [Abstract] [Full Text] [Related]

  • 19. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 20. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P, Jiao Y, Hao M, Tang X.
    J Cell Biochem; 2018 Jul 05; 119(7):5243-5252. PubMed ID: 29236322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.